-
1
Digital twins use AI and large datasets for rare diseases.
-
2
72% of rare diseases are genetically related.
-
3
Digital Patient Profiles (DPPs) enhance recruitment.
-
4
Historical data are limited, making trials challenging.
-
5
Mechanism-based evidence is becoming more accepted.
-
6
Predictive analysis improves investigator site selection.
-
7
Quality of data is critical for trust and transparency.
-
8
Pathology labs must adopt digital twins to keep pace.
Original Source(s)
Related Content
The Top 40 Under 40 Power List 2026: Nominations Are Open!
Nominate a rising star in analytical science
April 17, 2026
-
1 min
GLP-1 Drugs Linked to GI Effects, Uncertain Signals
Umbrella review evaluates over 1,700 trials to assess noncardiometabolic outcomes beyond weight and glycemic effects.
April 16, 2026
-
3 min
Why Extraction Still Matters in Food Analysis
Ahead of ExTech 2026, Hans-Gerd Janssen weighs in on the challenges and evolution of sample preparation
April 16, 2026
-
8 min